Jefferies analyst Kambiz Yazdi raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $141.00 (from $128.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE